TrialInvestigational new drugs2013

Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma.

Tara C Gangadhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.